Meizhu Bai

Meizhu Bai

Auto-generated profile, based on publicly available information

Meizhu Bai

Department of Genetics, Yale University School of Medicine, New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Cancer Immunology Research
Verified
Journal Article
Closed access
PRPaul Renauer
Paul Renauer
JPJonathan J. Park
Jonathan J. Park
MBMeizhu Bai
Meizhu Bai
AAArianny Acosta
Arianny Acosta
WLWon-Ho Lee
Won-Ho Lee
SCSidi Chen
Sidi Chen
Immune evasion is a critical step of cancer progression that remains a major obstacle for current T cell–based immunotherapies. Hence, we investigated whether it is possible to genetically reprogram T cells to exploit a common tumor-intrinsic evasion mechanism whereby cancer cells suppress T-cell function by generating a metabolically unfavorable tumor microenvironment (TME). In an in silico screen, we identified ADA and PDK1 as metabolic regulators. We then showed that overexpression (OE) of these genes enhanced the cytolysis of CD19-specific chimeric antigen receptor (CAR) T cells against cognate leukemia cells, and conversely, ADA or PDK1 deficiency dampened this effect. ADA-OE in CAR T cells improved cancer cytolysis under high concentrations of adenosine, the ADA substrate, and an immunosuppressive metabolite in the TME. High-throughput transcriptomics and metabolomics analysis of these CAR T cells revealed alterations of global gene expression and metabolic signatures in both ADA- and PDK1-engineered CAR T cells. Functional and immunologic analyses demonstrated that ADA-OE increased proliferation and decreased exhaustion in CD19-specific and HER2-specific CAR T cells. ADA-OE improved tumor infiltration and clearance by HER2-specific CAR T cells in an in vivo colorectal cancer model. Collectively, these data unveil systematic knowledge of metabolic reprogramming directly in CAR T cells and reveal potential targets for improving CAR T-cell therapy.

15 April 2020 in Development
Verified
Journal Article
Open access
PDF file
XWXiukun Wang
Xiukun Wang
JKJun-Yan Kang
Jun-Yan Kang
LWLeixin Wei
Leixin Wei
XYXiaogan Yang
Xiaogan Yang
HSHongduo Sun
Hongduo Sun
JLJingsong Li
Jingsong Li

26 November 2025
Verified
Other
Open access
PRPaul Renauer
Paul Renauer
JPJonathan J. Park
Jonathan J. Park
MBMeizhu Bai
Meizhu Bai
AAArianny Acosta
Arianny Acosta
WLWon-Ho Lee
Won-Ho Lee
SCSidi Chen
Sidi Chen
Immune evasion is a critical step of cancer progression that remains a major obstacle for current T cell–based immunotherapies. Hence, we investigated whether it is possible to genetically reprogram T cells to exploit a common tumor-intrinsic evasion mechanism whereby cancer cells suppress T-cell function by generating a metabolically unfavorable tumor microenvironment (TME). In an in silico screen, we identified ADA and PDK1 as metabolic regulators. We then showed that overexpression (OE) of these genes enhanced the cytolysis of CD19-specific chimeric antigen receptor (CAR) T cells against cognate leukemia cells, and conversely, ADA or PDK1 deficiency dampened this effect. ADA-OE in CAR T cells improved cancer cytolysis under high concentrations of adenosine, the ADA substrate, and an immunosuppressive metabolite in the TME. High-throughput transcriptomics and metabolomics analysis of these CAR T cells revealed alterations of global gene expression and metabolic signatures in both ADA- and PDK1-engineered CAR T cells. Functional and immunologic analyses demonstrated that ADA-OE increased proliferation and decreased exhaustion in CD19-specific and HER2-specific CAR T cells. ADA-OE improved tumor infiltration and clearance by HER2-specific CAR T cells in an in vivo colorectal cancer model. Collectively, these data unveil systematic knowledge of metabolic reprogramming directly in CAR T cells and reveal potential targets for improving CAR T-cell therapy.

7 May 2022 in Protein & Cell
Verified
Journal Article
Open access
PDF file
MBMeizhu Bai
Meizhu Bai
DLDan Liang
Dan Liang
YCYan Cheng
Yan Cheng
GLGuolong Liu
Guolong Liu
QWQiudao Wang
Qiudao Wang
YWYuxuan Wu
Yuxuan Wu
Correction to: Protein Cellhttps://doi.org/10.1007/s13238-022-00910-w

26 November 2025
Verified
Other
Open access
PRPaul Renauer
Paul Renauer
JPJonathan J. Park
Jonathan J. Park
MBMeizhu Bai
Meizhu Bai
AAArianny Acosta
Arianny Acosta
WLWon-Ho Lee
Won-Ho Lee
SCSidi Chen
Sidi Chen
Supplementary Table S9 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function